lanifibranor   Click here for help

GtoPdb Ligand ID: 12737

Synonyms: compound 5 [PMID: 29446942] | IVA-337 | IVA337
PDB Ligand
Compound class: Synthetic organic
Comment: Lanifibranor (IVA337) is a pan-peroxisome proliferator-activated receptor (PPAR) agonist that was developed as an antifibrotic clinical lead [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 120.72
Molecular weight 434.92
XLogP 2.05
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C(CC1=CC2=C(C=CC(=C2)Cl)N1S(=O)(=O)C3=CC4=C(C=C3)N=CS4)CC(=O)O
Isomeric SMILES ClC1=CC=C2N(S(=O)(C3=CC=4SC=NC4C=C3)=O)C(CCCC(O)=O)=CC2=C1
InChI InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)
InChI Key OQDQIFQRNZIEEJ-UHFFFAOYSA-N
References
1. Boubia B, Poupardin O, Barth M, Binet J, Peralba P, Mounier L, Jacquier E, Gauthier E, Lepais V, Chatar M et al.. (2018)
Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate.
J Med Chem, 61 (6): 2246-2265. [PMID:29446942]
2. Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L et al.. (2021)
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
N Engl J Med, 385 (17): 1547-1558. [PMID:34670042]